Evidence map›Paper›PMID 38602170›Full record

ArticleeLife2024

Statin-mediated reduction in mitochondrial cholesterol primes an anti-inflammatory response in macrophages by upregulating Jmjd3.

Zeina Salloum, Kristin Dauner, Yun-Feng Li, Neha Verma, David Valdivieso-González, Víctor Almendro-Vedia, John D Zhang, Kiran Nakka, Mei Xi Chen, Jeffrey McDonald and 7 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 4 countries.

Zeina SalloumChronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Canada.ORCID https://orcid.org/0000-0002-5216-8601
Kristin DaunerChronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Yun-Feng LiCollege of Life Sciences, Wuhan University, Wuhan, China.
Neha VermaChronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Canada.
David Valdivieso-GonzálezDepartamento Química Física, Universidad Complutense de Madrid, Avda, Madrid, Spain.
Víctor Almendro-VediaDepartamento Química Física, Universidad Complutense de Madrid, Avda, Madrid, Spain.ORCID https://orcid.org/0000-0002-7297-1901
John D ZhangChronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Kiran NakkaSprott Center for Stem Cell Research, Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Canada.ORCID https://orcid.org/0000-0002-8418-9343
Mei Xi ChenSprott Center for Stem Cell Research, Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Jeffrey McDonaldDepartment of Molecular Genetics, The University of Texas Southwestern Medical Center, Dallas, United States.
Chase D CorleyDepartment of Molecular Genetics, The University of Texas Southwestern Medical Center, Dallas, United States.
Alexander SoriskyChronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Bao-Liang SongCollege of Life Sciences, Wuhan University, Wuhan, China.
Iván López-MonteroDepartamento Química Física, Universidad Complutense de Madrid, Avda, Madrid, Spain.ORCID https://orcid.org/0000-0001-8131-6063
Jie LuoCollege of Life Sciences, Wuhan University, Wuhan, China.
Jeffrey F DilworthSprott Center for Stem Cell Research, Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Xiaohui ZhaChronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Canada.ORCID https://orcid.org/0000-0003-2873-3073
Ottawa Hospital · CAUniversidad Complutense de Madrid · ESWuhan University · CNThe University of Texas Southwestern Medical Center · USUniversity of Ottawa · CAUniversity of Wisconsin–Madison · US

Funding

TRANSCRIPTIONAL REGULATION OF LDL RECEPTOR PROMOTERP01HL020948 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI GOLDSTEIN, JOSEPH L · 1985 to 2021
$103.1M
UT Southwestern NORCP30DK127984 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI JAY D. HORTON · 2022 to 2026
$7.4M
CIHR PJT-180504Heart and Stroke Foundation of Canada G-19-0026359NHLBI NIH HHS P01 HL020948NIDDK NIH HHS P30 DK127984NIH HHS HL020948Regional Government of Madrid S2018/BAA-4403SINOXPHOS-CM
6 · The paper itself

Abstract

Statins are known to be anti-inflammatory, but the mechanism remains poorly understood. Here, we show that macrophages, either treated with statin in vitro or from statin-treated mice, have reduced cholesterol levels and higher expression of

Indexed as

CholesterolHydroxymethylglutaryl-CoA Reductase InhibitorsJumonji Domain-Containing Histone DemethylasesMacrophagesMitochondriaUp-RegulationAnimalsAnti-Inflammatory AgentsMaleMiceMice, Inbred C57BLAnti-Inflammatory AgentsCholesterolHydroxymethylglutaryl-CoA Reductase InhibitorsJumonji Domain-Containing Histone DemethylasesKdm6b protein, mousecell biologycholesterolinflammationmacrophagesmouse

Identifiers

PMID38602170
PMCPMC11186637
OpenAlexW4394725634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.